This study is being done to learn more about long-term use of evolocumab, safety and tolerability, and whether its chronic administration is associated to any side effects

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-004066-26

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- To describe the safety and tolerability of long-term administration of evolocumab.


Critère d'inclusion

  • Dyslipidemia